Gynecologic oncology is a specific field of medication that centers around malignant growths of the female regenerative framework, including ovarian disease, uterine malignant growth, vaginal malignancy, cervical disease, and vulvar malignant growth. As masters, they have broad preparing in the finding and treatment of these tumors.

In the United States, 82,000 ladies are determined to have gynecologic disease yearly. In 2013, an expected 91,730 were analyzed.

The Society of Gynecologic Oncology and the European Society of Gynecological Oncology are proficient associations for gynecologic oncologists, and the Gynecologic Oncology Group is an expert association for gynecological oncologists just as other clinical experts who manage gynecologic diseases. The Foundation for Women's Cancer is the major U.S. association that brings issues to light and examination financing and gives instructive projects and materials about gynecologic diseases.

There is low quality proof which shows ladies with gynecological malignancy getting treatment from particular focuses advantage from longer endurance than those oversaw in standard consideration. A meta investigation of three examinations joining more than 9000 ladies, proposed that expert gynecological malignant growth treatment focuses may draw out the lives of ladies with ovarian disease contrasted and general or network medical clinics. What's more, a meta‐analysis of three different examinations which evaluated more than 50,000 ladies, found that instructing focuses or concentrated malignant growth habitats may draw out ladies' lives contrasted with those rewarded in network or general medical clinics.